Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Sara Tolaney MD, MPH
Sara M. Tolaney MD, MPH Advisory Board
Roger Stupp MD
Roger Stupp MD Advisory Board
Annette Hasenburg Prof., Dr, med
Annette Hasenburg Prof., Dr, med Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · June 27, 2022

Prognostic Impact of FDG-PET Response After CAR T-Cell Therapy in Patients With Relapsed/Refractory Large B-Cell Lymphoma

Haematologica

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Charles Gaulin MBBS

Haematologica
PET-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T-cells
Haematologica 2022 Jun 09;[EPub Ahead of Print], J Galtier, L Vercellino, L Chartier, P Olivier, C Tabouret-Viaud, C Mesguich, R Di Blasi, A Durand, L Raffy, FX Gros, I Madelaine, V Meignin, M Mebarki, MT Rubio, P Feugier, O Casasnovas, M Meignan, C Thieblemont

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated